July 26, 2004
The National Cancer Institute (NCI) will announce solicitation for the 2004 SBIR contract proposals in August 2004. Companies can apply for funds to design targetry to produce novel radionuclides and separate them and to create radiochemicals with automated synthesis modules.
The resulting daily availability of such radionuclides as Cu-64 or I-124 can lead investigators to the development of novel radiopharmaceuticals for PET-based molecular imaging and for therapy.
This NCI initiative is highly complementary to the current SNM program for National Radionuclide Availability and the result of the SNM-NCI joint workshop, which was held in September 2003.
SNM is very pleased about this NCI initiative.